On the upside
The Food and Drug Administration will allow Dynavax (Nasdaq: DVAX) to continue drug trials of its hepatitis B vaccine.
J. P. Morgan upgraded United Airlines parent UAL (Nasdaq: UAUA) .
Skyworks (Nasdaq: SWKS) lifted its fourth quarter guidance citing improving demand.
On the downside
Photronics (Nasdaq: PLAB) announced that it will sell $50 million in senior convertible notes in order to pay down debt.
Navistar International (NYSE: NAV) swung to a third quarter loss that fell far short of expectations and cut its full year outlook.
Monsanto (NYSE: MON) will eliminate approximately 8 percent of its staff, a deeper cut than originally announced.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 7 to 5 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 2 points to 583.